按照协议，礼来公司将启动一项“真实世界”研究，旨在了解替西帕肽（tirzepatide，其Zepbound和Mounjaro药物背后的GLP-1受体激动剂药物）如何影响减肥、糖尿病预防和肥胖相关并发症的预防，以更好地为英国国家卫生服务局（NHS）应对 ...

Obesity treatment should start at a young age, he said, because if you have overweight at ages 3-6 years, the likelihood of ...

‘Fat’ jabs, ‘skinny’ jabs, ‘anti-obesity’ medications – weight-loss drugs come with many names. A favourite amongst celebs ...

Listen to Story Britain will study if Eli Lilly's weight loss drug can help reduce long-term sickness England's ... The deal included "a major real-world study into obesity" on the effectiveness of ...

The U.K. is exploring whether obesity drugs could be used to curb joblessness after signing a major investment deal with ...

The medical supply company is leaning on its plants in Canada, China, Ireland, and the U.K. to shore up reserves hurt by flooding of its North Carolina plant.

A study on the "real-world" effectiveness of weight loss drugs is set to measure the impact on the job prospects of people ...

Eli Lilly (NYSE: LLY) plans to invest $206M to expand its Suzhou, China site for Type 2 diabetes and obesity drugs. The ...

Britain is studying the use of Eli Lilly's weight loss drug, Tirzepatide, to address long-term sickness impacting its economy ...

Patients will first be eligible to receive the drug if they have a BMI over 40 and at least three of specified weight-related ...

Researchers will examine the ‘real-world effectiveness’ of anti-obesity treatment Mounjaro, also known as tirzepatide, over a ...

Federal regulators shook up the booming weight loss drug marketplace when they announced Mounjaro and Zepbound to be no ...